FCA's Reach At Stake As DOJ Jumps Into 1st Circ. Fight

Law360, New York (August 14, 2013, 5:03 PM ET) -- Drugmakers are poised to gain valuable cover from False Claims Act liability for failing to report patient harm in a case pending at the First Circuit, but the Obama administration is fighting back, warning that fully upholding the district court's ruling would dangerously narrow the law's scope.

Until recently, the matter seemed like a run-of-the-mill whistleblower suit, in which a onetime medical reviewer at Takeda Pharmaceutical Co. Ltd. accused her former employer of inducing fraudulent reimbursements by not disclosing adverse events involving several of its medicines,...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required